1
-
10
of
10
results (0.44 seconds)
Sort By:
-
Critical Illness Turns 40!
Critical Illness Turns 40! This article provides an overview of critical illness insurance: history, product description, and the three primary ways to offer critical illness coverage in the ...- Authors: Jennifer Howard, Ashlee Borcan
- Date: Sep 2023
- Competency: External Forces & Industry Knowledge; Technical Skills & Analytical Problem Solving
- Publication Name: Health Watch
- Topics: Experience Studies & Data; Experience Studies & Data>Morbidity; Health & Disability; Health & Disability>Critical illness insurance; Health & Disability>Health insurance; Experience Studies & Data>Rate calculations; Health & Disability>Incidence; Health & Disability>Rates - Health & Disability; Health & Disability>Termination - Health & Disability
-
Our Value-Based Cup Runneth Over
Our Value-Based Cup Runneth Over Discussion of how to mature value-based contracts between health insurers and provider organizations to improve population health and financial sustainability.- Authors: Daniel Reck (Dan), Lisa Swan, Sam Johnmeyer
- Date: Aug 2022
- Competency: Communication; External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Enterprise Risk Management>Risk appetite; Enterprise Risk Management>Risk measurement - ERM; Health & Disability>Chronic health management - Health & Disability; Health & Disability>Health care quality; Health & Disability>Health insurance; Health & Disability>Payment models; Health & Disability>Provider risk
-
Give Me Some Credibility: Addressing the Challenge of Volatility in Value-Based Contracts—Part 2
Give Me Some Credibility: Addressing the Challenge of Volatility in Value-Based Contracts—Part 2 Discover the key components of value-based care (VBC) contracts and their impact on provider ...- Authors: Maria Knox, James Pisko, Keith Passwater
- Date: May 2023
- Competency: External Forces & Industry Knowledge; Results-Oriented Solutions; Technical Skills & Analytical Problem Solving
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health insurance; Predictive Analytics; Health & Disability>Provider networks; Health & Disability>Provider risk; Predictive Analytics>Modeling techniques
-
Issue Brief: Changing Financial Risks for Medigap Insurance, Part 1
Issue Brief: Changing Financial Risks for Medigap Insurance, Part 1 During the past few years, performance, cost, and risk trends for Medigap products have undergone substantial changes. Some of ...- Authors: Kristi Bohn
- Date: Mar 2024
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health insurance
-
Biosimilars, Part 3: Humira Biosimilar Launches
Biosimilars, Part 3: Humira Biosimilar Launches The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Medicare Supplement and FASB’s Long-Duration Targeted Improvements Project Part II: Conclusions
Medicare Supplement and FASB’s Long-Duration Targeted Improvements Project Part II: Conclusions In ...- Authors: Rowen Bell
- Date: Aug 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Financial Reporting & Accounting; Financial Reporting & Accounting>Generally Accepted Accounting Principles [GAAP]; Health & Disability; Health & Disability>Health insurance
-
Additional Actuarial Perspectives on Prescription Drug Financing
Additional Actuarial Perspectives on Prescription Drug Financing Introduction to additional actuarial research into development of and regulatory impact, economic impact and consumer impact of ...- Authors: Gregory L Warren
- Date: Apr 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care quality; Health & Disability>Health insurance; Health & Disability>Health risks; Health & Disability>Public financing - Health & Disability
-
Biosimilars, Part 4: The Financial Impact
Biosimilars, Part 4: The Financial Impact Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can ...- Authors: Greg Warren, Tony Pistilli
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Biosimilars, Part 5: Payer Decision Making
Biosimilars, Part 5: Payer Decision Making The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many ...- Authors: Greg Warren, Tony Pistilli
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Chronic health management - Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance
-
Issue Brief: Changing Financial Risks for Medigap Insurance, Part 2
Issue Brief: Changing Financial Risks for Medigap Insurance, Part 2 This is Part 2 of 2 on changes affecting Medigap insurers. It focuses on marketing and regulatory differences between Medigap ...- Date: Mar 2024
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health insurance; Public Policy; Public Policy